Table 2.
Treatment descriptions of the patients
| IVMP | IVIG | PE | Efgartigimod | Concomitant medications | Ventilator weaning | Tracheotomy | Decannulation | Duration of ICU stay | Duration of MV | |
|---|---|---|---|---|---|---|---|---|---|---|
| Case 1 | Yes | Yes | No | Yes | CS 40 mg, Pyd 60 mg q6h, Tac 3 mg | Yes | Yes | 17 | 16 | |
| Case 2 | Yes | Yes | No | Yes | CS 40 mg, Pyd 60 mg t.i.d, MMF 500 mg | Yes | Yes | 24 | 23 | |
| Case 3 | Yes | Yes | No | Yes | CS 40 mg, Pyd 60 mg q8h, Tac 2 mg | Yes | Yes | 18 | 16 | |
| Case 4 | Yes | No | No | Yes | CS 40 mg, Pyd 60 mg q6h, Tac 3 mg | Yes | Yes | 18 | 15 | |
| Case 5 | Yes | Yes | No | Yes | CS 40 mg, Pyd 60 mg q8h, Tac 3 mg | Yes | Yes | Yes | 48 | 52 |
IVMP = intravenous high-dose methylprednisolone; IVIG = intravenous immunoglobulin; PE = plasma exchange; ICU = intensive care unit; MV = mechanical ventilation